Insider: Fenimore Christopher R. SVP Finance & CFO - REGENERON PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 18,460 | 1,378 | 19,838 |
| Value | $10,295,695.80 | $768,551.94 | $11,064,247.74 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/28/2024 | DDS | 2,237 | Indirect | COM | $1,204.71 | $2,694,936.27 | 1,378 |
| 08/28/2024 | DDS | 200 | Indirect | COM | $1,206.30 | $241,260.00 | 0 |
| 08/28/2024 | DDS | 200 | Indirect | COM | $1,206.67 | $241,334.00 | 25 |
| 08/28/2024 | DDS | 228 | Indirect | COM | $1,204.79 | $274,692.12 | 966 |
| 08/28/2024 | DDS | 928 | Indirect | COM | $1,205.49 | $1,118,694.72 | 450 |
| 08/28/2024 | DDS | 766 | Indirect | COM | $1,205.44 | $923,367.04 | 200 |
| 08/28/2024 | DDS | 450 | Indirect | COM | $1,206.15 | $542,767.50 | 0 |
| 08/28/2024 | DDS | 200 | Indirect | COM | $1,206.70 | $241,340.00 | 25 |
| 08/28/2024 | DDS | 235 | Indirect | COM | $1,205.67 | $283,332.45 | 225 |
| 08/28/2024 | DDS | 236 | Indirect | COM | $1,205.67 | $284,538.12 | 225 |
| 02/09/2024 | DDS | 487 | Direct | COM | $951.39 | $463,326.93 | 18,460 |
| 02/09/2024 | DDS | 344 | Direct | COM | $950.49 | $326,968.56 | 18,947 |
| 02/09/2024 | DDS | 1,046 | Direct | COM | $952.62 | $996,440.52 | 17,414 |
| 02/09/2024 | DDS | 1,100 | Direct | COM | $954.57 | $1,050,027.00 | 14,972 |
| 02/09/2024 | DDS | 1,342 | Direct | COM | $953.47 | $1,279,556.74 | 16,072 |
| 02/09/2024 | DDS | 600 | Direct | COM | $955.00 | $573,000.00 | 14,372 |
| 12/27/2023 | DDS | 2,448 | Direct | COM | $856.71 | $2,097,226.08 | 14,372 |
| 12/22/2023 | DDS | 250 | Direct | COM | $846.27 | $211,567.50 | 16,820 |
| 12/21/2023 | DDS | 1,224 | Direct | COM | $844.09 | $1,033,166.16 | 17,070 |
| 12/21/2023 | DDS | 456 | Direct | COM | $843.79 | $384,768.24 | 18,294 |
| 03/23/2023 | DDS | 2,192 | Direct | COM | $806.47 | $1,767,782.24 | 18,409 |
| 10/05/2022 | DDS | 1,844 | Direct | COM | $749.00 | $1,381,156.00 | 16,425 |
| 10/03/2022 | DDS | 3,346 | Direct | COM | $724.00 | $2,422,504.00 | 18,269 |
| 08/23/2021 | DDS | 23 | Direct | COM | $660.33 | $15,187.59 | 27,912 |
| 08/23/2021 | DDS | 4,576 | Direct | COM | $655.00 | $2,997,280.00 | 27,944 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research